Russell C. Langan

2.7k total citations · 1 hit paper
62 papers, 2.1k citations indexed

About

Russell C. Langan is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Russell C. Langan has authored 62 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 29 papers in Surgery and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Russell C. Langan's work include Pancreatic and Hepatic Oncology Research (23 papers), Cancer Genomics and Diagnostics (7 papers) and Neuroendocrine Tumor Research Advances (7 papers). Russell C. Langan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (23 papers), Cancer Genomics and Diagnostics (7 papers) and Neuroendocrine Tumor Research Advances (7 papers). Russell C. Langan collaborates with scholars based in United States, Netherlands and Serbia. Russell C. Langan's co-authors include Udai S. Kammula, Jeremy L. Davis, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Carolyn M. Laurençot, Marybeth S. Hughes, Mark E. Dudley, Giao Q. Phan and Nicholas P. Restifo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gut.

In The Last Decade

Russell C. Langan

55 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis

2010 791 citations James C. Yang, Russell C. Langan et al. profile →

Peers

Countries citing papers authored by Russell C. Langan

Since Specialization

Citations

This map shows the geographic impact of Russell C. Langan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell C. Langan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell C. Langan more than expected).

Fields of papers citing papers by Russell C. Langan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell C. Langan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell C. Langan. The network helps show where Russell C. Langan may publish in the future.

Co-authorship network of co-authors of Russell C. Langan

This figure shows the co-authorship network connecting the top 25 collaborators of Russell C. Langan. A scholar is included among the top collaborators of Russell C. Langan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell C. Langan. Russell C. Langan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estimating the Survival Impact of Curative-Intent Liver Therapies for Colorectal Cancer Liver Metastases 2025 ·Annals of Surgical Oncology ·(unknown), Elizabeth A. Handorf, Benjamin Bates, David G. Brauer, Patrick M. Boland, (unknown), Mariam F. Eskander, Miral S. Grandhi, (unknown), Hari S. Iyer, Timothy J. Kennedy, Russell C. Langan, J. Carlos Maggi, Henry A. Pitt, Elisa V. Bandera, Alexander A. Parikh, Brett L. Ecker	0
2	Racial disparities in rates of invasiveness of resected intraductal papillary mucinous neoplasms in the United States 2024 ·Surgery ·(unknown), (unknown), H. Richard Alexander, (unknown), Mariam F. Eskander, Miral S. Grandhi, Haejin In, Timothy J. Kennedy, Russell C. Langan, J. Carlos Maggi, Dirk F. Moore, Henry A. Pitt, (unknown), (unknown), Brett L. Ecker	0
3	Association between SMAD4 Mutations and GATA6 Expression in Paired Pancreatic Ductal Adenocarcinoma Tumor Specimens: Data from Two Independent Molecularly-Characterized Cohorts 2023 ·Biomedicines ·(unknown), (unknown), H. Richard Alexander, (unknown), Mariam F. Eskander, Miral S. Grandhi, Timothy J. Kennedy, Russell C. Langan, J. Carlos Maggi, Subhajyoti De, Colin M. Court, Brett L. Ecker	0
4	Pancreatectomy for intraductal papillary mucinous neoplasm: has anything changed in North America? 2023 ·HPB ·Catherine H. Davis, (unknown), Russell C. Langan, Miral S. Grandhi, Timothy J. Kennedy, David A. August, H. Richard Alexander, Henry A. Pitt	1
5	Pancreatic Gangliocytic Paraganglioma: A Rare Neuroendocrine Neoplasm 2023 ·Pancreas ·(unknown), Catherine H. Davis, (unknown), J. Carlos Maggi, Brett L. Ecker, J. Kirk Harris, Russell C. Langan	0
6	Association between SMAD4 mutations and GATA6 expression in pancreatic adenocarcinoma specimens 2023 ·HPB ·Praveen D. Chatani, Colin M. Court, David A. August, (unknown), Miral S. Grandhi, Hoh Peter In, Timothy J. Kennedy, J. Carlos Maggi, Henry A. Pitt, Alice C. Wei, Russell C. Langan, Brett L. Ecker	1
7	Expression of PD-L1 in Patients With Malignant Peritoneal Mesothelioma: A Pilot Study 2022 ·Journal of Surgical Research ·(unknown), (unknown), Alissa Greenbaum, (unknown), Chunxia Chen, Dirk F. Moore, Russell C. Langan, Timothy J. Kennedy, (unknown), H. Richard Alexander	4
8	Impact of postoperative complications on long‐term survival after esophagectomy in older adults: A SEER‐Medicare analysis 2021 ·Journal of Surgical Oncology ·(unknown), (unknown), (unknown), (unknown), Zubin M. Bamboat, (unknown), Russell C. Langan, (unknown), Patrick Hilden, Subroto Paul	5
9	Robotic pancreatoduodenectomy: trends in technique and training challenges 2021 ·HPB ·Catherine H. Davis, Miral S. Grandhi, (unknown), Alissa Greenbaum, T. L. Kennedy, Russell C. Langan, Hamish Alexander, Henry A. Pitt, David A. August	1
10	A Prospective Analysis of Quality of Life and Toxicity Outcomes in Treating Early Breast Cancer With Breast Conservation Therapy and Intraoperative Radiation Therapy 2018 ·Frontiers in Oncology ·Michael Sosin, (unknown), (unknown), (unknown), Aistė Gulla, Alex J. Bartholomew, Suzanne C. O’Neill, Elizabeth M. Hechenbleikner, Brian T. Collins, Sonali Rudra, Sean P. Collins, Krysta Chaldekas, (unknown), Russell C. Langan, Shawna C. Willey, Eleni A. Tousimis	12
11	Medicaid beneficiaries undergoing complex surgery at quality care centers: insights into the Affordable Care Act 2016 ·The American Journal of Surgery ·Erin Hall, Chaoyi Zheng, Russell C. Langan, Lynt B. Johnson, Nawar Shara, Waddah B. Al‐Refaie	9
12	Pancreaticoduodenectomy hospital resource utilization in octogenarians 2015 ·The American Journal of Surgery ·Russell C. Langan, Chun-Chih Huang, (unknown), Katherine M. Harris, (unknown), (unknown), (unknown), Patrick G. Jackson, Reena Jha, Nadim Haddad, J.E. Carroll, Jane Hanna, (unknown), Waddah B. Al‐Refaie, Lynt B. Johnson	19
13	Readmissions after major cancer surgery among older adults 2015 ·Surgery ·Russell C. Langan, Chun-Chih Huang, (unknown), Arnold L. Potosky, Lynt B. Johnson, Nawar Shara, Waddah B. Al‐Refaie	17
14	Hospital-level resource use by the oldest-old for pancreaticoduodenectomy at high-volume hospitals 2015 ·Surgery ·Russell C. Langan, Chaoyi Zheng, Katherine M. Harris, (unknown), Waddah B. Al‐Refaie, Lynt B. Johnson	10
15	Laparoscopic-assisted versus open pancreaticoduodenectomy: Early favorable physical quality-of-life measures 2014 ·Surgery ·Russell C. Langan, Jay A. Graham, (unknown), (unknown), (unknown), Jeffrey D. Nusbaum, John Smirniotopoulos, Reilly Kayser, Reena Jha, Nadim Haddad, Firas Al‐Kawas, J.E. Carroll, Jane Hanna, (unknown), Waddah B. Al‐Refaie, Lynt B. Johnson	66
16	Serum-Based DNA Methylation Biomarkers in Colorectal Cancer: Potential for Screening and Early Detection 2013 ·Journal of Cancer ·Thomas A. Summers, Russell C. Langan, Aviram Nissan, Björn L.D.M. Brücher, Anton J. Bilchik, Mladjan Protić, Martin Däumer, Itzhak Avital, Alexander Stojadinovic	36
17	Establishment of Human Ultra-Low Passage Colorectal Cancer Cell Lines Using Spheroids from Fresh Surgical Specimens Suitable for In Vitro and In Vivo Studies 2012 ·Journal of Cancer ·Satyajit Ray, Russell C. Langan, John E. Mullinax, Tomotake Koizumi, Hong-Wu Xin, Gordon Wiegand, (unknown), Alexander Stojadinovic, Snorri S. Thorgeirsson, Udo Rudloff, Itzhak Avital	16
18	A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers 2012 ·Journal of Cancer ·Russell C. Langan, John E. Mullinax, Satyajit Ray, Manish T. Raiji, Nicholas P. Schaub, Hong-Wu Xin, Tomotake Koizumi, Seth M. Steinberg, Andrew J. Anderson, Gordon Wiegand, Donna Butcher, Miriam R. Anver, Anton J. Bilchik, Alexander Stojadinovic, Udo Rudloff, Itzhak Avital	48
19	Assessment of Ovarian Function After Preparative Chemotherapy and Total Body Radiation for Adoptive Cell Therapy 2011 ·Journal of Immunotherapy ·Russell C. Langan, Peter A. Prieto, Richard M. Sherry, Daniel Zlott, John R. Wunderlich, György Csákó, Rene Costello, Donald E. White, Steven A. Rosenberg, James C. Yang	16
20	CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma 2010 ·Clinical Cancer Research ·Mark E. Dudley, Colin Gross, Michelle M. Langhan, Marcos Ríos García, Richard M. Sherry, James C. Yang, Giao Q. Phan, Udai S. Kammula, Marybeth S. Hughes, Deborah E. Citrin, Nicholas P. Restifo, John R. Wunderlich, Peter A. Prieto, Jenny J. Hong, Russell C. Langan, Daniel Zlott, Kathleen E. Morton, Donald E. White, Carolyn M. Laurençot, Steven A. Rosenberg	245

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact